183 related articles for article (PubMed ID: 21141477)
21. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
Pearce MB; Belser JA; Houser KV; Katz JM; Tumpey TM
Vaccine; 2011 Apr; 29(16):2887-94. PubMed ID: 21338676
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
Gubareva LV; Penn CR; Webster RG
Virology; 1995 Oct; 212(2):323-30. PubMed ID: 7571401
[TBL] [Abstract][Full Text] [Related]
24. Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
Lee SM; Gai WW; Cheung TK; Peiris JS
Antiviral Res; 2011 Sep; 91(3):330-4. PubMed ID: 21798291
[TBL] [Abstract][Full Text] [Related]
25. Comparison of real-time RT-PCR, shell vial culture, and conventional cell culture for the detection of the pandemic influenza A (H1N1) in hospitalized patients.
López Roa P; Catalán P; Giannella M; García de Viedma D; Sandonis V; Bouza E
Diagn Microbiol Infect Dis; 2011 Apr; 69(4):428-31. PubMed ID: 21396540
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
27. Mutations in influenza virus replication and transcription: detection of amino acid substitutions in hemagglutinin of an avian influenza virus (H1N1).
Liu N; Wang G; Lee KC; Guan Y; Chen H; Cai Z
FASEB J; 2009 Oct; 23(10):3377-82. PubMed ID: 19553505
[TBL] [Abstract][Full Text] [Related]
28. [Properties of reassortants of human and avian influenza viruses. Reproduction in MDCK cells at suboptimum temperatures].
Finskaia NN; Smirnov IuA; Rudneva IA; Kaverin NV
Mol Gen Mikrobiol Virusol; 1988 Apr; (4):26-9. PubMed ID: 3405232
[TBL] [Abstract][Full Text] [Related]
29. Anti-influenza virus activity of Myrica rubra leaf ethanol extract evaluated using Madino-Darby canine kidney (MDCK) cells.
Mochida K
Biosci Biotechnol Biochem; 2008 Nov; 72(11):3018-20. PubMed ID: 18997411
[TBL] [Abstract][Full Text] [Related]
30. [Surveillance program set for influenza A virus (H1N1) in children in Taiyuan, China, 2005-2006].
Lan T; Wang NC; Chang YH; Peng GX; Na DY; Zhang CY; Wu LP
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Aug; 28(8):753-5. PubMed ID: 18080559
[TBL] [Abstract][Full Text] [Related]
31. miR-21-3p Regulates Influenza A Virus Replication by Targeting Histone Deacetylase-8.
Xia B; Lu J; Wang R; Yang Z; Zhou X; Huang P
Front Cell Infect Microbiol; 2018; 8():175. PubMed ID: 29888214
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus.
Yamada K; Ogawa H; Hara A; Yoshida Y; Yonezawa Y; Karibe K; Nghia VB; Yoshimura H; Yamamoto Y; Yamada M; Nakamura K; Imai K
Antiviral Res; 2009 Jul; 83(1):35-44. PubMed ID: 19501255
[TBL] [Abstract][Full Text] [Related]
33. An NA-deficient 2009 pandemic H1N1 influenza virus mutant can efficiently replicate in cultured cells.
Inoue E; Ieko M; Takahashi N; Osawa Y; Okazaki K
Arch Virol; 2014 Apr; 159(4):797-800. PubMed ID: 24142272
[TBL] [Abstract][Full Text] [Related]
34. Mathematical model of influenza A virus production in large-scale microcarrier culture.
Möhler L; Flockerzi D; Sann H; Reichl U
Biotechnol Bioeng; 2005 Apr; 90(1):46-58. PubMed ID: 15736163
[TBL] [Abstract][Full Text] [Related]
35. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells.
Song L; Liu H; Gao S; Jiang W; Huang W
J Virol; 2010 Sep; 84(17):8849-60. PubMed ID: 20554777
[TBL] [Abstract][Full Text] [Related]
36. Infection of human retinal pigment epithelial cells with influenza A viruses.
Michaelis M; Geiler J; Klassert D; Doerr HW; Cinatl J
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5419-25. PubMed ID: 19553611
[TBL] [Abstract][Full Text] [Related]
37. Seasonal, avian, and novel H1N1 influenza: prevention and treatment modalities.
Sym D; Patel PN; El-Chaar GM
Ann Pharmacother; 2009 Dec; 43(12):2001-11. PubMed ID: 19920156
[TBL] [Abstract][Full Text] [Related]
38. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
39. MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres.
van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
Vaccine; 2011 Sep; 29(40):6976-85. PubMed ID: 21787829
[TBL] [Abstract][Full Text] [Related]
40. HA-pseudotyped retroviral vectors for influenza antagonist screening.
Wang SY; Su CY; Lin M; Huang SY; Huang WI; Wang CC; Wu YT; Cheng TJ; Yu HM; Ren CT; Wu CY; Wong CH; Cheng YS
J Biomol Screen; 2009 Mar; 14(3):294-302. PubMed ID: 19211776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
